Profil
Ronald C.
Seubert is the founder.
He founded Applied Precision, Inc. in 1986 and held the title of Executive Chairman in 2010.
He also founded RareCyte, Inc. in 2009 and currently holds the title of Chairman.
Mr. Seubert received his undergraduate degree from Gonzaga University.
Postes actifs de Ronald C. Seubert
| Sociétés | Poste | Début |
|---|---|---|
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Fondateur | 01/01/2009 |
Anciens postes connus de Ronald C. Seubert
| Sociétés | Poste | Fin |
|---|---|---|
Applied Precision, Inc.
 Applied Precision, Inc. Medical SpecialtiesHealth Technology Applied Precision provides researchers with the most advanced high-resolution and super-resolution imaging platforms which turn the unobservable into the observable. Since its founding in 1986, Applied Precision has become a leader in imaging innovation through their dedication to problem-solving, superior engineering, and performance. They take pride in delivering flexible, automated, and superior imaging systems with the highest level of service and consultation, such that their customers can immediately answer their scientific questions. They are dedicated to helping researchers with their individual needs and providing them with tools to collect the high-quality data needed to advance scientific discoveries. Applied Precision has cultivated an environment of teamwork and problem-solving and recognizes the importance of balancing work with personal time. Their team of engineers, technicians, managers and sales and marketing professionals are passionate, meticulous, resourceful and unwilling to compromise in quality. Applied Precision has been recognized through numerous awards for innovative products and strong financial growth and has sold instruments worldwide. | Directeur Général | - |
Formation de Ronald C. Seubert
| Gonzaga University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Applied Precision, Inc.
Applied Precision, Inc. Medical SpecialtiesHealth Technology Applied Precision provides researchers with the most advanced high-resolution and super-resolution imaging platforms which turn the unobservable into the observable. Since its founding in 1986, Applied Precision has become a leader in imaging innovation through their dedication to problem-solving, superior engineering, and performance. They take pride in delivering flexible, automated, and superior imaging systems with the highest level of service and consultation, such that their customers can immediately answer their scientific questions. They are dedicated to helping researchers with their individual needs and providing them with tools to collect the high-quality data needed to advance scientific discoveries. Applied Precision has cultivated an environment of teamwork and problem-solving and recognizes the importance of balancing work with personal time. Their team of engineers, technicians, managers and sales and marketing professionals are passionate, meticulous, resourceful and unwilling to compromise in quality. Applied Precision has been recognized through numerous awards for innovative products and strong financial growth and has sold instruments worldwide. | Health Technology |
RareCyte, Inc.
RareCyte, Inc. Medical SpecialtiesHealth Technology RareCyte Inc. develops life science research and diagnostic that focuses on characterizing and isolating rare cells in the blood. It engages in bringing its technology to the life sciences research, drug development and diagnostic markets providing new tools to answer difficult questions related to cancer and cardiovascular disease. It's ground-breaking sccuCyte system is an open platform for the unbiased discovery and isolation of circulating tumor cells and circulating endothelial cells from whole blood. The company was founded by Ronald Seubert in 2009 and is headquartered in Seattle, WA. | Health Technology |
